Skip to main content
SpringerLink
Log in

Quantifizierung von Genexpressionen beim Prostatakarzinom

Welche endogenen Referenzgene sind geeignet?

  • Leitthema
  • Published:
Der Urologe Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Andersen CL, Jensen JL, Orntoft TF (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64: 5245–5250

    Article  PubMed  CAS  Google Scholar 

  2. Jung M, Ramankulov A, Roigas J et al. (2007) In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR. BMC Mol Biol 8: 47

    Article  PubMed  Google Scholar 

  3. Ohl F, Jung M, Radonic A et al. (2006) Identification and validation of suitable endogenous reference genes for gene expression studies in human bladder cancer. J Urol 175: 1915–1920

    Article  PubMed  CAS  Google Scholar 

  4. Ohl F, Jung M, Xu C et al. (2005) Gene expression studies in prostate cancer tissue: which reference gene should be selected? J Mol Med 83: 1014–1024

    Article  PubMed  CAS  Google Scholar 

  5. Pfaffl MW (2004) Real-time RT-PCR: Neue Ansätze zur exakten mRNA-Quantifizierung. Biospektrum 10: 92–95

    CAS  Google Scholar 

  6. Vandesompele J, De Preter K, Pattyn F et al. (2007) GeNorm software manual. Update März 13, 2007 http://www.medgen.ugent.be/~jvdesomp/genorm/geNorm_manual.pdf

Download references

Author information

Authors and Affiliations

  1. Klinik für Urologie, Charité - Universitätsmedizin Berlin,Charité Campus Mitte, Charitéplatz 1, 10117, Berlin, Deutschland

    M. Jung, F. Ohl, C. Stephan, A. Rabien, S.A. Loening & K. Jung

  2. Institut für Pathologie, Charité - Universitätsmedizin Berlin, Charité Campus Mitte, Berlin, Deutschland

    G. Kristiansen

  3. Klinik für Innere Medizin II (Onkologie und Hämatologie), Charité - Universitätsmedizin Berlin, Charité Campus Mitte, Berlin, Deutschland

    A. Radonić

Authors
  1. M. Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Ohl
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Stephan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Rabien
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Kristiansen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Radonić
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S.A. Loening
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. K. Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Jung.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jung, M., Ohl, F., Stephan, C. et al. Quantifizierung von Genexpressionen beim Prostatakarzinom. Urologe 46, 1083–1084 (2007). https://doi.org/10.1007/s00120-007-1436-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-007-1436-0

Search

Navigation